Report Feature
The future of the global CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) market looks promising with opportunities in the biomedical, agricultural, industrial, and biological research applications. The global CRISPR market is expected to grow with a CAGR of 24%-26% from 2020 to 2025. The major drivers for this market are increasing prevalence of genetic diseases, rising geriatric population, and increasing lifestyle oriented diseases.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global CRISPR market report, please download the report brochure.
The study includes trends and forecast for the global CRISPR market by product, service, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Enzymes
- Kits
- gRNA (Guide RNA)
- Libraries
- Design Tools
By Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- gRNA Design
- Cell Line Engineering
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biomedical
- Agricultural
- Industrial
- Biological Research
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharma & Biopharma Companies
- Biotechnology Companies
- Academics
- Contract Research Organization (CROs)
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the CRISPR companies profiled in this report include Cellecta, Thermo Fisher, GeneCopoeia, Applied StemCell, Synthego, OriGene Technologies, Horizon Discovery, Merck, and GenScript.
Within this market, biomedical will remain the largest segment by application over the forecast period due to CRISPR’s ability to modify endogenous genes that helps in studying the effect of drugs on targets along with endogenous proteins, rather than having to rely on overexpression.
North America will remain the largest region over the forecast period due to increasing government and private fundings and the presence of major gene therapy and pharma companies in the region.
|
Features of the Global CRISPR Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global CRISPR market by product (enzymes, kits, gRNA, libraries, and design tools), service (gRNA design and cell line engineering), application (biomedical, agricultural, industrial, and biological research), end user (pharma & biopharma companies, biotechnology companies, academics, and contract research organization), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global CRISPR market? Q.5 What are the business risks and threats to the global CRISPR market? Q.6 What are the emerging trends in this CRISPR market and the reasons behind them? Q.7 What are some changing demands of customers in this CRISPR market? Q.8 What are the new developments in this CRISPR market? Which companies are leading these developments? Q.9 Who are the major players in this CRISPR market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this CRISPR market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global CRISPR market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Enzymes, Kits, gRNA, Libraries, and Design Tools), Service (gRNA Design and Cell Line Engineering), Application (Biomedical, Agricultural, Industrial, and Biological Research), and End User (Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global CRISPR Market
4.1 Global CRISPR Market by Region
4.2.1 Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.2.2 Market by Service: gRNA Design and Cell Line Engineering
4.2.3 Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.2.4 Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.2.5 The United States CRISPR Market
4.2.6 The Canadian CRISPR Market
4.2.7 The Mexican CRISPR Market
4.3.1 Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.3.2 Market by Service: gRNA Design and Cell Line Engineering
4.3.3 Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.3.4 Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.3.5 The CRISPR Market of United Kingdom
4.3.6 The German CRISPR Market
4.3.7 The French CRISPR Market
4.4.1 Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.4.2 Market by Service: gRNA Design and Cell Line Engineering
4.4.3 Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.4.4 Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.4.5 The Chinese CRISPR Market
4.4.6 The Indian CRISPR Market
4.4.7 The Japanese CRISPR Market
4.5.1 Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.5.2 Market by Service: gRNA Design and Cell Line Engineering
4.5.3 Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.5.4 Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.5.5 Brazilian CRISPR Market
7.1.1 Growth Opportunities for the Global CRISPR Market by Product
7.1.2 Growth Opportunities for the Global CRISPR Market by Service
7.1.3 Growth Opportunities for the Global CRISPR Market by Application
7.1.4 Growth Opportunities for the Global CRISPR Market by End User
7.1.5 Growth Opportunities for the Global CRISPR Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
